CEACAM6 Activators
CEACAM6 activators belong to a specialized class of chemical compounds designed to modulate the activity of CEACAM6, which stands for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6. CEACAM6 is a cell surface glycoprotein that is part of the larger CEACAM family, a group of adhesion molecules involved in various cellular processes, including cell adhesion, signaling, and immune responses. CEACAM6 is particularly noteworthy for its presence in a variety of human tissues and its association with certain cancers, where it can be overexpressed. In normal physiological contexts, CEACAM6 plays a role in cell-cell adhesion and tissue organization, but its overexpression in cancer has raised interest in understanding its roles in tumor development and progression.
CEACAM6 activators are synthesized compounds designed to interact with CEACAM6, modulating its activity and influencing cellular processes. These compounds are important tools for researchers studying the molecular mechanisms of CEACAM6 and its implications in cancer biology. By manipulating CEACAM6 activity, scientists aim to gain insights into its functions in tumor cell behavior, such as adhesion, migration, and signaling. CEACAM6 activators play a critical role in advancing our understanding of the intricate cellular processes associated with cancer and contribute to the broader field of cell adhesion and tumor biology, providing valuable information on the molecular basis of cancer development and progression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
A tyrosine kinase inhibitor that can modulate EGF signaling, potentially influencing CEACAM6. | ||||||
Exendin-4 | 141758-74-9 | sc-474611 sc-474611A | 500 µg 1 mg | $143.00 $194.00 | 1 | |
A glucagon-like peptide-1 agonist, influencing insulin signaling and potentially CEACAM6. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $100.00 $408.00 | 6 | |
An anti-fibrotic agent, possibly influencing TGF-β pathways and indirectly CEACAM6. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $178.00 $648.00 $1657.00 | 3 | |
A multi-targeted tyrosine kinase inhibitor, might affect FGF pathways and subsequently CEACAM6. | ||||||
XL-184 free base | 849217-68-1 | sc-364657 sc-364657A | 5 mg 10 mg | $92.00 $204.00 | 1 | |
An inhibitor of multiple tyrosine kinases including HGF receptor, potentially influencing CEACAM6. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates immune responses and might influence IFN-γ pathways, indirectly affecting CEACAM6. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
A glucocorticoid that can modulate inflammation and possibly influence CEACAM6 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A derivative of retinoic acid, involved in cell differentiation, may impact CEACAM6 expression. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
A PPAR agonist, influencing lipid metabolism and inflammation, potentially affecting CEACAM6. | ||||||